0001708138-20-000068.txt : 20200610
0001708138-20-000068.hdr.sgml : 20200610
20200610160445
ACCESSION NUMBER: 0001708138-20-000068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200610
DATE AS OF CHANGE: 20200610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20954719
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-08
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001585160
Landry Robert E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Finance CFO
Common Stock
2020-06-08
4
M
0
3500
272.7
A
27873
D
Common Stock
2020-06-08
4
F
0
2536
592.43
D
25337
D
Common Stock
2020-06-08
4
M
0
3500
272.7
A
28837
D
Common Stock
2020-06-08
4
F
0
2536
592.43
D
26301
D
Common Stock
2020-06-08
4
M
0
2500
272.7
A
28801
D
Common Stock
2020-06-08
4
F
0
1811
592.4
D
26990
D
Common Stock
2020-06-08
4
M
0
2250
272.7
A
29240
D
Common Stock
2020-06-08
4
F
0
1630
592.43
D
27610
D
Common Stock
2020-06-08
4
M
0
2250
272.7
A
29860
D
Common Stock
2020-06-08
4
F
0
1630
592.43
D
28230
D
Common Stock
2020-06-08
4
M
0
1500
272.7
A
29730
D
Common Stock
2020-06-08
4
F
0
1086
592.43
D
28644
D
Common Stock
2020-06-09
4
S
0
110
602.38
D
28534
D
Common Stock
2020-06-09
4
S
0
131
603.68
D
28403
D
Common Stock
2020-06-09
4
S
0
50
604.14
D
28353
D
Common Stock
2020-06-09
4
S
0
289
605.14
D
28064
D
Common Stock
2020-06-09
4
S
0
353
606.79
D
27711
D
Common Stock
2020-06-09
4
S
0
619
607.47
D
27092
D
Common Stock
2020-06-09
4
S
0
1511
608.5
D
25581
D
Common Stock
2020-06-09
4
S
0
681
609.53
D
24900
D
Common Stock
2020-06-09
4
S
0
527
610.25
D
24373
D
Common Stock
200
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
272.7
2020-06-08
4
M
0
3500
0.0
D
2023-09-09
Common Stock
3500
15500
D
Non-Qualified Stock Option (right to buy)
272.7
2020-06-08
4
M
0
3500
0.0
D
2023-09-09
Common Stock
3500
12000
D
Non-Qualified Stock Option (right to buy)
272.7
2020-06-08
4
M
0
2500
0.0
D
2023-09-09
Common Stock
2500
9500
D
Non-Qualified Stock Option (right to buy)
272.7
2020-06-08
4
M
0
2250
0.0
D
2023-09-09
Common Stock
2250
7250
D
Non-Qualified Stock Option (right to buy)
272.7
2020-06-08
4
M
0
2250
0.0
D
2023-09-09
Common Stock
2250
5000
D
Non-Qualified Stock Option (right to buy)
272.7
2020-06-08
4
M
0
1500
0.0
D
2023-09-09
Common Stock
1500
3500
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 110 shares of Company stock on June 9, 2020 at prices ranging from $602.35 to $602.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 131 shares of Company stock on June 9, 2020 at prices ranging from $603.33 to $603.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 289 shares of Company stock on June 9, 2020 at prices ranging from $605.07 to $605.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 353 shares of Company stock on June 9, 2020 at prices ranging from $606.46 to $606.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 619 shares of Company stock on June 9, 2020 at prices ranging from $607.00 to $607.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,511 shares of Company stock on June 9, 2020 at prices ranging from $608.14 to $608.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 681 shares of Company stock on June 9, 2020 at prices ranging from $609.41 to $609.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 527 shares of Company stock on June 9, 2020 at prices ranging from $610.00 to $610.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert E. Landry
2020-06-10